From $EAPH concerning their clinical, "We believe that the products we are developing will be classified as cosmetics or Class I medical devices. Products classified as cosmetics may be marketed and sold in the US without FDA approval. Drugs are not cosmetics and those, as well as OTC drugs, must be marketed following FDA regulations and/or approvals in the United States. Before human testing can begin with respect to a new drug in the United States, preclinical studies are conducted in laboratory animals to evaluate the potential efficacy and the safety of a product. Human clinical studies generally involve a three-phase process. The initial clinical evaluation, Phase I, consists of administering the product and testing for safe and tolerable dosage levels. Phase II trials continue the evaluation of safety and determine the appropriate dosage for the product, identify possible side effects and risks in a larger group of subjects, and provide preliminary indications of efficacy. Phase III trials consist of testing for actual clinical efficacy within an expanded group of patients at geographically dispersed test sites.
From $EAPH concerning their clinical, "We believe that the
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Molina Healthcare Class Action Lawsuit: Investors Take Action
Legal Update for Molina Healthcare Investors Attention all investors: This is a crucial time for shareholders of Molina Healthcare, Inc. (NYSE: MOH) as a significant class action lawsuit has recently been initiated. This announcement comes from a prestigious law firm, dedicated to defending the rights of investors facing substantial financial losses. If you're among those...
Continue Reading
Health Recovery Solutions Enhances Remote Patient Monitoring
Health Recovery Solutions Partners with Smart Meter Health Recovery Solutions (HRS), a prominent leader in Remote Patient Monitoring (RPM), is excited to announce its strategic partnership with Smart Meter. This collaboration aims to enhance their renowned PatientConnect system by integrating new cellular measurement devices, providing a cost-effective alternative to...
Continue Reading
Utilities and REITs Experience a Surge Amid Interest Rate Outlook
Utilities Surge as Market Sentiment Changes Recently, there’s been a noticeable shift in market sentiment, with a growing focus on defensive equity sectors, especially utilities. This change has allowed utility shares to outperform many others, standing out as the leading performers among various sector ETFs. Noteworthy Utility Performance The Utilities Select Sector...
Continue Reading
Mobile Video Surveillance Market Projected to Reach $4 Billion
Mobile Video Surveillance Market Growth Overview The mobile video surveillance market is on a promising trajectory, expected to expand from USD 2.78 billion to USD 4.00 billion by 2030, with a compound annual growth rate (CAGR) of 7.5%. This growth is fueled by an increasing demand for security across various industries and a rising tide of security concerns. Importance...
Continue Reading
Lupaka Gold Navigates Post-Arbitration Landscape for Asset Recovery
Lupaka Gold's Commitment to Asset Recovery Following Arbitration Lupaka Gold Corp. is proactively addressing the recent arbitration award against the Republic of Peru following a successful outcome. The company is confident that Peru will uphold its commitments under international law and pay the awarded amount. However, in light of this situation, Lupaka is taking...
Continue Reading